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ABSTRACT  Near confluent  monolayers of  arterial  smooth  muscle cells derived from  Macaca 
nemestrina were labeled with Na2[aSS]O4 and the newly synthesized proteoglycans present in 
the culture medium  and cell layer were extracted with either 4 M  guanidine HCI (dissociative 
solvent) or 0.5 M  guanidine HCI  (associative solvent)  in the  presence of  protease inhibitors. 
The  proteoglycans  in  both  compartments  were  further  purified  by cesium  chloride  density 
gradient ultracentrifugation. Two size classes of  proteoglycans were observed in the medium 
as  determined  by  chromatography  on  Sepharose  CL-2B.  The  large  population  ("Kay =  0.31) 
contained predominantly chondroitin sulfate chains with Mr =  ~40,000. The smaller population 
(Kay =  0.61)  contained dermatan sulfate chains of similar Mr (~40,000). When  tested for their 
ability to aggregate, only proteoglycans in the large-sized population were able to aggregate. 
A chondroitin sulfate containing proteoglycan with identical properties was isolated from  the 
cell  layer.  In addition, the cell  layer contained  a dermatan  sulfate component which  eluted 
later on Sepharose CL-2B  (Kay =  0.78)  than the dermatan  sulfate proteoglycan  present in the 
medium.  Electron  microscopy of  the  purified  proteoglycans revealed a  bottlebrush structure 
containing a central core averaging 140 nm in length with an average of 8 to 10 side projections. 
The  length  of  the  side  projections  varied  but  averaged  between  70  and  75  nm.  Similar 
bottlebrush  structures were  observed  in  the  intercellular  matrix  of  the  smooth  muscle  cell 
cultures  after  staining with  Safranin  0.  This culture  system  provides a  model  to  investigate 
parameters involved in the regulation of synthesis and degradation of arterial proteoglycans. 
Proteoglycans and  their  constituent  glycosaminoglycans are 
present in blood vessel walls (1-14) and form important struc- 
tural links between the fibrous components of the intercellular 
matrix (collagen and elastic fibers) and the arterial endothelial 
and smooth muscle cells (15). Recently, considerable attention 
has  focused on these  macromolecules since  they  have  been 
shown to influence the structural integrity of the vascular wall 
and to affect several arterial properties such as viscoelasticity, 
permeability,  lipid  metabolism,  hemostasis,  and  thrombosis 
(15,  16). Furthermore, their participation in such cell processes 
as proliferation (17),  migration (18),  and adhesion (19)  high- 
light their importance in many events that are common to both 
blood vessel development and disease. 
Although several  studies  have investigated  changes in  the 
glycosaminoglycan component of arterial proteoglycans during 
development and disease  (10,  11,  15, 20),  only recently have 
attempts been made to define the physical-chemical nature of 
entire proteoglycan molecules isolated from arteries.  This in- 
formation is important since it is thought that the structure of 
the  whole  molecule,  and  not  merely  the  component  parts, 
dictates  the  functional  properties  of the  proteoglycans.  Em- 
ploying methods used to isolate proteoglycans from cartilage, 
Oegema et al.  (5)  found two size classes  of proteoglycans in 
bovine aorta: a polydisperse population of chondroitin sulfate 
and  dermatan  sulfate  and  a  smaller  population  containing 
heparan sulfate.  Gardell et al.  (8) demonstrated that some of 
the  aortic proteoglycans shared  antigenic  determinants  with 
those  from cartilage  and  were  able  to form high  molecular 
weight  aggregates.  The  ability  of arterial  proteoglycans  to 
aggregate was later confirmed by McMurtrey (7) who isolated 
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recently,  Salisbury  and  Wagner (6)  isolated  two  major  size 
classes  of proteoglycans from human aorta and found that the 
larger population contained predominantly chondroitin sulfate 
while  the  smaller  population  contained  dermatan  sulfate. 
Heparan sulfate proteoglycan appeared to be distributed  be- 
tween  these  two  populations  when  separated  by  molecular 
sieve chromatography. These findings indicate that there are 
at least three distinct  species of proteoglycans present  in the 
arterial wall. 
Cell culture techniques have allowed a closer examination 
of the cell  types responsible  for the synthesis of the arterial 
proteoglycans.  To  date,  most  studies  have  concentrated  on 
defining the types of glycosaminoglycans that both endothelial 
and smooth muscle cells  synthesize and secrete (21-28).  En- 
dothelial  cells  synthesize  less  total  glycosaminoglycans but 
markedly more heparan sulfate than smooth muscle ceils (27). 
On the other hand, smooth muscle cells synthesize significant 
amounts of chondroitin sulfate and dermatan  sulfate (21-25) 
and, like the situation in vivo, the relative amounts of each of 
these  isomers produced  by these  cells  depend  on the  donor 
species  as well as the portion of the vasculature that was used 
to isolate the cells. Although these studies in vitro have iden- 
tified the cell types responsible for synthesizing particular types 
of arterial glycosaminoglycans, little is known about the classes 
of proteoglycans to which these  glycosaminoglycans belong. 
Furthermore,  it is not known how proteoglycans synthesized 
by arterial cells in vitro compare to those proteoglycans present 
in intact arteries. 
The objective of the present  study was to investigate bio- 
chemical and morphological characteristics of the proteogly- 
cans synthesized by nonhuman primate arterial smooth muscle 
cells in culture to develop a model system for studying param- 
eters involved in the regulation of synthesis and degradation of 
arterial  proteoglycans in  vivo.  The  results  demonstrate  that 
arterial smooth muscle cells derived from subhuman primates 
synthesize at least two distinctly different proteoglycans which 
are very similar  to those found in human aorta and  in part 
resemble proteoglycans present in some canilagenous tissues. 
MATERIALS  AND  METHODS 
Materials:  Guanidine HCI, cesium chloride, and papain were all pur- 
chased from Sigma Chemical Co.,  St.  Louis, MO; 6-aminohexanoic acid and 
benzamidine HC1  from  Eastman Kodak Co.,  Rochester,  NY; chondroitinase 
ABC (Proteus vulgaris) and chondroitinase AC lI (Arthrobacter aurescens) from 
Seikagaku, Kogyo, Tokyo, Japan, through Miles Laboratories, Inc., Elkhart, IN; 
Sephadex and Sepharose from Pharmacia, Inc., Piscataway, N J; Na2[aSS]O4 (~ 10 
mCi/ml:  106 mCi/mmol), D-[6-3H]-glucosamine  (--1.0 mCi/ml: 31  Ci/mmol) 
and Aquasol from New England Nuclear, Boston, MA; Dulbecco Vogt medium, 
Gibco Laboratories, Grand Island Biological Co., Grand Island, NY; flasks and 
petri dishes, Falcon Plastics, Oxnard,  CA. The monomer,  DI, and aggregate, 
aAl 1, were prepared from the Swarm rat chondrosarcoma (29). 2 
Cell  Culture:  Arterial smooth  muscle cells were established by  the 
method of Ross (30). Strips of intimal-medial tissue from the thoracic aorta of 1- 
2-year-old pigtail monkeys (Macaca nemestrina) were explanted in Dulbecco- 
Vogt modification of Eagle's minimal medium supplemented with 5% homolo- 
gous serum. Cells were allowed to grow to confluency, at which time they were 
trypsinized and passed. The passed cells were then plated in either 60-mm petri 
dishes in 4.0 ml of medium or in 75-cm  :~ T-flasks in l0 ml of medium and allowed 
Nomenclature: D 1, D2, D3, and D4 indicate fractions recovered from 
the bottom to top of dissociative density gradients and aA 1, aA2, aA3 
and aA4 fractions from bottom to top of associative density gradients 
prepared directly from associative extracts as described in reference 29. 
The tumor was originally kindly provided by Dr. Theodore Oegema, 
University  of  Minnesota,  Minneapolis,  MN;  and  was  subsequently 
maintained by transplantation (29). 
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to grow to confluency in a  humidified atmosphere of 5% CO2 and 95% air at 
37°C. 
Radioisotope  Labeling  of Cultures  and Extraction  of Pro- 
teoglycans:  Near confluent cultures were labeled by the addition of fresh 
medium containing Na._,['~S]O4 (50 ,ttCi/ml) for 48 h unless otherwise specified. 
Some experiments involved double labeling with Na213~S]O4 (50/~Ci/ml) and 
[aH] D-glucosamine (2.5  /tCi/ml). After labeling, the incubation medium was 
removed and either 0.8 g/ml or 0.05 g/ml of solid guanidine HCI was added to 
make the medium ~4 M or ~0.5 M,  respectively (31).  The resulting solutions 
were immediately frozen and stored at -70°C  until subsequent analysis. The 
remaining cell layers were washed twice with phosphate-buffered saline at 0°C 
for 1-2 min. The washes did not contain significant amounts of macromolecular 
radiolabeled material and were discarded. The cell layers were then extracted 
with either 1 ml (60-ram dishes) or 5 ml (75-cm  2 flask) of 4 M guanidine HC1 
(dissociative  solvent) or 0.5 M guanidine HCI (associative solvent) containing 0.1 
M 6-aminohexanoic acid, 5 mM benzamidine HCI, 50 mM sodium EDTA, and 
50 mM sodium acetate, pH 5.8. The cell layers were disrupted by scraping with 
a  rubber  policeman,  extracted in  the  cold  with constant  stirring for  1-2  h, 
centrifuged briefly at  12,000 rpm  for 2  rain to remove insoluble residue, and 
stored at -70°C until analyzed. 
Relative Hydrodynamic 5izes of the Proteoglycan Mono- 
mers:  Aliquots (200 ~l) of the 4  M guanidine HCI extracts of the medium 
and cell layer were mixed with 30 ,ul of monomer proteoglycan carrier ( 10 mg/ml 
in 4  M  guanidine HCI) and the mixture was applied directly to an analytical 
Sepharos¢ CL-2 B gel filtration column (110 × 0.7 cm) eluted with 4 M guanidine 
HCI in 0.05 M sodium acetate buffer, pH 5.8 at room temperature. Fractions (0.6 
ml) were collected under 40-50 cm hydrostatic pressure at a flow rate of ~2.0 
ml/h. Each fraction was mixed with l ml of 70% ethanol and 10 ml of Aquasol 
and analyzed for radioactivity in a Packard Tri Curb Scintillation Counter. 
Equilibrium Density Gradient Cen trifuga tion 
DISSOCIATIVE DENSITY GRADIENTS:  Aliquots, l mi of the medium and 
cell layer extracts, were mixed with 100/d of monomer proteoglycan carrier (10 
mg/ml in 4 M guanidine HC1) and chromatographed on PD-10 columns in the 
presence of 4 M guanidine HCI to remove unincorporated isotope (32). Excluded 
volume fractions were pooled and 0.5 g of cesium chloride was added per gram 
of solution to yield a starting density of 1.45 g/mL The gradients were centrifuged 
for 60 h  at  10~C at 37,000  rpm in a  Beckman SW 50.1 Rotor (33)  (Beckman 
Instuments, Inc., Fullerton, CA). Gradients were divided into four approximately 
equal fractions, DI  through  D41  (29),  by means of a  tube slicer or gradient 
separator (Buchler Int., Chicago, IL). The specific gravity of each fraction was 
determined by weighing 50-~1 aliquots on a Mettler microbalance. The amounts 
of macromolecular laSS]activity were determined by liquid scintillation  counting. 
Fractions were dialyzed extensively against distilled water, and portions were 
lyophilized. An aliquot of each fraction was chromatographed on a  Sepharose 
CL-2B analytical column eluted with 4  M  guanidine HCI in 0.05  M  sodium 
acetate buffer, pH 5.8. 
ASSOCIATIVE DENSITY GRADIENT:  0.5 M guanidine HCI extracts of the 
medium and cell layer were prepared for associative gradients directly (i.e.  no 
carrier added and no PD-10 column used to remove unincorporated isotope) by 
adding 0.9 g of cesium chloride per gram of solution to yield a starting density of 
1.53 g/ml.  Centrifugation was done  as described above.  The  gradients were 
divided into four equal fractions, aAl through aA4  t (29). The aAl fraction was 
dialyzed exhaustively against distilled water to remove unincorporated isotope 
and used for the electron microscopy and the aggregation experiments described 
below. 
Characterization  of the Glycosaminoglycans:  The major pro- 
teoglycan populations in the medium and cell layer extract were isolated from 
the bottom half of the dissociative density gradient (D1 and D2) by preparative 
Sepharose CL-2B chromatography (0.9 x  60 cm) eluted with 4 M guanidine HC1 
in 0.05  M sodium acetate buffer, pH 5.8. Fractions were pooled to recover the 
major peaks (see Fig. 4), dialyzed, and lyophilized. Glycosaminoglycans in each 
proteoglycan population were released by papain digestion (30 #g/ml in 0.1 M 
sodium acetate, pH 7.0 for 4  h  at 65°C) (34)  or by alkaline degradation (35). 
Ahquots of the released glycosaminoglycans  were chromatographed on a Seph- 
arose CL-6B column (0.7  x  30 cm), eluted with 0.2 M NaCI, 20 mm Tris HCI, 
pH 7.5.  Fractions of 0.22 ml were collected and 0.10 ml of each fraction was 
taken for measurement of radioactivity.  The excluded (Vo) and total (Vt) volumes 
of the  column were determined by  using blue  dextran  and  free  [:)SS]sulfate, 
respectively. The average molecular weight, Mr, of the released glycosaminogly- 
cans was estimated by comparing the elution position (partition coefficient = K,v) 
of the sample fractions to known chondroitin sulfate standards as described by 
Wasteson (36). The remainder of each fraction in the glycosaminoglycan peak 
for each sample was pooled and the glycosaminoglycans  present were precipitated 
by adding 3 vol of 95% ethanol: 1.3% (wt/vol) potassium acetate. Precipitates were 
cooled to 0°C and isolated by centrifugation at 10,000 rpm. The precipitates were dissolved in distilled water and then digested either with 0.03 ml of chondroitinase 
ABC (10 U/m[ in 0.3 M Tns) or with 0.03 ml of chondroitinase AC II (10 U/ml 
in  0.3  M  Tris).  The  relative  amounts  of the  isomeric sulfated  disaccharide 
digestion products were determined by paper chromatography (37). 
Proteoglycan Aggregation:  Aliquots (250 #1) of the aAl fractions 
prepared  directly  from  both  the  medium  and  cell  layer  without  carrier  as 
described above were mixed with 30/d of carrier proteoglycan aggregate, aA l 
(29) (10 mg/ml in 0_5 M sodium acetate, 2.5 mM EDTA, pH 7.0). The mixture 
was eluted on an analytical Sepharose CL-2B column (0.7 x  ll0 cm) with the 
same buffer that contained the sample. The amount of [S~S]activity eluting in the 
void volume of the column provides an estimate of the amount of proteoglycan 
present as aggregate in the samples (38). 
The  ability of proteoglycans in  Dl  fractions to  aggregate was also tested. 
Aliquots of the D 1 fractions in 4 M guanidine HCI (300 ~tl) were mixed with 100 
/tl of carrier proteoglycan aggregate, aA l from rat chondrosarcoma  ( 10 mg/ml in 
4 M guanidine HC1). The mixture was dialyzed overnight against 0.5 M sodium 
acetate, 2.5 mM EDTA, pH 7.0 and applied to an analytical associative Sepharose 
CL-2B column eluted  with  the  same  buffer. The  percentage of radioactivity 
eluting  in  the  void  volume  of the  column  provides  an  estimate  of labeled 
proteoglycan monomer that can interact with hyaluronic acid to form aggregates. 
Electron Microscopy of Isolated Proteoglycans:  Aliquots of 
the  aAl  fractions prepared directly without added carrier as described above 
were spread on electron microscopic grids by the DNA spreading technique as 
modified by Rosenberg et al. (39) and, more recently, by Kimura et al. (40) and 
Hascall (41). For each sample, ~75 #1 of a 1:5 dilution of aA 1 in 0.3 M ammonium 
acetate was mixed with 25 pl of cytochrome c solution (I mg/ml in 1 mM Tris, 
1 mM EDTA, pH 8.5) and left at room temperature for 1 h. A 25-pl aliquot was 
then layered on a 0.3 M ammonium acetate hypophase, pH 5.0, via a wet glass 
ramp. The  thin  film  produced was transferred to  Formvar-coated grids and 
stained  for 30 s  in  diluted  uranyl acetate in  ethanol. The  grids were  rotary 
shadowed with carbon platinum-palladium at low angles (6-10  °) and observed 
in a  JEOL  100-B electron microscope at 60 kV and a  magnification of 70,000 
times. The monomer lengths and widths were obtained by tracing contours of 
well-spread monomers on photographs printed at 70,000 times with a  Hewlett- 
Packard digitizer (Model 48309A) coupled to a  computer program capable of 
providing size frequency and distribution and basic statistics. 
Electron Microscopy of Proteoglycans  within the Matrix of 
Arterial Smooth Muscle Cell Cultures:  Representative  monolayers 
were fixed in 2% glutaraldehyde in 0.1 M Sorenson's sodium phosphate, pH 7.4, 
containing 0.1% Safranin O (42) for 1 h at room temperature. Subsequently, the 
cultures were rinsed thoroughly in phosphate buffer containing 0.2 M  sucrose 
and &05%  Safranin O  before postfixation in  2%  osmium tetroxide in  0.1  M 
sodium phosphate plus 0.025% Safranin O. After a rinse in phosphate buffer, the 
monolayers were dehydrated and embedded in epoxy resin as previously de- 
scribed (25). Thin sections were cut with a diamond knife on an LKB Ultratome 
Ill, double-stained with uranyl acetate and lead citrate, and examined in a JEOL 
100-B electron microscope at 60 kV. 
The specificity of this staining procedure for identifying proteoglycans was 
confirmed by incubating representative monolayers with chondroitinase ABC 
(0.5 U/ml) in 0.2 M  enriched Tris buffer for  I  h  at 37°C (25). Controls were 
incubated with buffer without enzyme. After enzyme treatment, the monolayers 
were rinsed and processed as described above. 
RESULTS 
The amount of [aSS]-labeled macromolecules released into the 
medium by arterial smooth muscle cells and  present in 4  M 
guanidine HCI extracts of the cell layer at various times after 
beginning continuous labeling are shown in Fig. 1. The release 
of the [3sS]-labeled macromolecules into the medium was linear 
for at least 48 h, while the amount of incorporated radioactivity 
present in the 4 M guanidine HCI extracts of the cell layer first 
increased linearly for -  16 h and then reached a plateau, staying 
fairly constant up to 48 h.  After 48 h,  uptake of Na2[aSS]O4, 
-70-80% of the [35S]-labeled  macromolecules were present in 
the medium. 
Samples of the medium and cell layer from cultures labeled 
for 48 h were chromatographed on Sepharose CL-2B with 4 M 
guanidine HCI as the elutant. Two major peaks of [~S]activity 
were observed for both the medium and cell layer (Fig. 2). The 
first peak, with the largest proteoglycan species (K,v -  0.31), 
eluted similarly for both the medium and cell layer samples. 
The second labeled peak eluted later for the sample from the 
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FIGURE  2  Sepharose CL-2B elution profile in 4 M guanidine HCI of 
asS-labeled macromolecules extracted from the medium (top panel) 
and cell layer (bottom panel). 
cell layer (Kay =  0.78) than for the medium (Kay =  0.61).  In 
addition, a small amount of macromolecular radioactivity (5- 
10% of the total) always eluted in the excluded volume of the 
column in extracts  of the cell layer, but this [~sS]-labeled  peak 
was not observed in the medium sample. 
The  smaller  proteoglycans  in  the  second  peaks  were  not 
derived from degradation of proteoglycans in the first  peaks. 
This  was  shown  by eluting  aliquots  of 4  M  guanidine  HC1 
extracts  of the  medium  and cell  layer  on  Sepharose  CL-2B 
obtained from cultures labeled for 8, 16, and 24 h (Fig. 3A). At 
8 h,  the second peak present  in the medium sample was the 
predominant  peak,  while  by  16  h  and  later,  the  first  peak 
became predominant. These data indicate  that  the first  peak, 
containing  the  large  proteoglycans,  increased  relative  to the 
second  peak  with  time  of  labeling  and  argues  against  the 
smaller proteoglycans being a breakdown product of the larger. 
The ratio of label in the two populations was nearly constant 
with time for proteoglycans extracted from the cell layer (Fig. 
3B). 
Portions of the 4 M  guanidine HC1 solution of the medium 
and  of the  extract  of the  cell layer were  fractionated in  a 
dissociative cesium chloride equilibrium density gradient after 
removing unincorporated radioactive precursors by chroma- 
tography on PD- 10 columns. As shown in Table I, the majority 
of the  [asS]-labeled macromolecules present in  both samples 
were recovered in the high density fractions (Dl and D2). The 
lowest density fraction (D4) from the medium contained the 
least amount  of [35S]-labeled  macromolecules (12%).  On  the 
other hand, considerably more [35S]activity (27%)  was present 
in the D4 fraction of the cell layer. The results indicate that the 
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TABLE  I 
Distribution of Radioactivity in a Dissociative CsCI Density 
Gradient Centrifugation * 
Medium  Cell layer 
Sp gravity  [35S]-DPM  Sp gravity  [aSS]-DPM 
g/m~  x  704  g/ml  x  704 
D4  1.37  5.5 (12%)  1.39  5.1  (27%) 
D3  1.40  5.9 (13%)  1.44  2.4 (13%) 
D2  1.48  14.2 (32%)  1.51  5.2 (28%) 
DI  1.66  19.1 (43%)  1.61  6.2 (33%) 
* These samples were prepared from ~6 x  10  e cells incubated with 50,aCi/ml 
of Na2[a%]O4  for 48 h. ~70%  of the total [aSS] macromolecular activity was 
secreted  into the medium while 30% of the [aSS] macromolecular material 
was associated  with the cell layer. Of the material present in the medium, 
~80% of it was recovered in the gradient. Similarly, 70% of the macromolec- 
ular  [asS] activity was recovered from  the cell  layer in  the gradient.  The 
percent unextracted (i.e., left after extraction of the cell layer) accounted for 
<5% of the total radioactivity. 
proteoglycans  present in the two culture compartments separate 
somewhat differently in the density gradient. 
Sepharose CL-2B profiles of each fraction of the dissociative 
gradient (D 1 to D4) from the medium revealed that the large 
proteoglycans were predominantly present in the denser frac- 
tions (DI and D2) (Fig. 4A), while the smaller proteoglycans 
were  predominant in  the  less dense  fractions (D3  and  D4). 
However,  the  denser  fractions  also  contained  a  significant 
amount of the smaller proteoglycan population and no single 
population was restricted to only one fraction. Gel chromatog- 
raphy of  the D 1 to D4 fractions of  the cell layer extract revealed 
that the smaller of the [asS]-labeled  peaks was present through- 
out  the  gradient,  but  that  the  larger proteoglycans and  the 
species that eluted in the excluded volume were confined to 
the denser fractions (Fig. 4 B). The D4 fraction of the cell layer 
is enriched in the smaller [asS]-labeled populations which con- 
tains two size classes of [35S]-labeled macromolecules with Kay 
=  0.66 and 0.80, respectively. The D4 fraction was not further 
analyzed. 
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Characterization  of  the Glycosaminoglycans 
Combined portions of D 1 and D2 from the medium and cell 
layer were eluted on a preparative CL-2B column and peaks I 
and II equivalent to those indicated in Fig. 4 recovered. Ali- 
quots of each peak were either digested with papain or alkaline 
degraded to release glycosaminoglycan chains. Papain diges- 
tion  and  alkaline degradation  gave  identical profiles when 
chromatographed on  Sepharose CL-6B  (Fig. 5).  The glycos- 
aminoglycans  isolated from  peak  I  present  in  the  medium 
eluted at a position which corresponds to a  molecular weight 
of ~40,000 (Fig. 5). This value was obtained by comparing the 
elution position of the isolated glyeosaminoglycans  to standard 
fractions of chondroitin  sulfate of known  molecular weight 
from bovine nasal cartilage as described by Wasteson (36). The 
glycosaminoglycan chains isolated from the smaller proteogly- 
can population, peak II, from the medium were identical to 
those present in the large population, indicating that the size of 
the glycosaminoglycan  chain does not contribute to differences 
in the hydrodynamic sizes of the two populations of proteogly- 
cans produced by the cultured ceils. Released glycosaminogly- 
cans from peaks I  and  1I in  the cell layer presented similar 
profdes when chromatographed on Sepharose CL-6B (Fig. 5). 
The isolated glycosaminoglycan  chains were treated with either 
chondroitinase ABC or chondroitinase AC II and the digests 
analyzed by paper chromatography as described in Materials 
and Methods.  Approximately 90%  of peak I  in the medium 
and cell layer was chondroitinase ABC:chondroitinase II-sen- 
sitive, indicating that the majority of peak I contained chon- 
droitin sulfate. On the other hand, peak II contained material 
that was 90% susceptible to chondroitinase ABC, but 20--30% 
insensitive to chondroitinase AC II, indicating the presence of 
dermatan sulfate  a chains. It is possible that all of the glycos- 
3 Dermatan sulfate was calculated  by comparison  of the amount of 
[~S]- in the chondroitin  4-sulfate position after digestion with chon- 
droitinase  ABC  and  chondroitinase  AC  II, although  it  should  be 
recognized that this method  can overestimate the iduronic acid in a 
heteropolymer. See reference 31. I  CL 28  4%~ 
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tive  CsCl  density  gradient of  35S-labeled  macro- 
molecules in the (a) medium and (b) cell layer. The 
solid bar indicates the fractions pooled for subse- 
quent  glycosaminoglycan  analysis.  Vo,  void  vol- 
ume;  Vr, total volume. 
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FIGURE  5  Sepharose CL-6B  elution profiles of released glycosami- 
noglycans from the major proteoglycan populations present in the 
D1 fraction in the medium and cell layer after papain digestion. (a) 
peak I medium, (b) peak I cell layer, (c) peak II medium, and (d) 
peak  II  cell  layer.  Fractions  of  0.22  ml  were collected.  Vo, void 
volume,  Vt, total volume. 
aminoglycans in this  fraction contain a  small proportion of 
iduronic acid and would be considered to be dermatan sulfate 
with a low percentage of iduronic acid residues. Alternatively, 
there may be a mixture of chondroitin sulfate chains (with no 
iduronic  acid)  and  dermatan  sulfate  chains  with  a  higher 
iduronic acid content. Detailed analysis of glycosaminoglycans 
in each peak is the subject of a following manuscript (Chang 
et al. Manuscript in preparation.). 
Proteoglycan Aggregation 
Samples of the medium in 0.5 M  guanidine HCI and of an 
associative extract of the cell layer were subjected to cesium 
chloride centrifugation under association conditions. As shown 
in Table II, the majority of the [3~S]-labeled macromolecules in 
the  medium  and  cell  layer  samples  were  recovered  in  the 
denser, aA1 fraction (sp gr 1.6-l.7 g/ml). An aliquot of each 
aAl  fraction  was  subsequently  mixed  with  carrier  aA!  in 
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TABLE  II 
Distribution of Radioactivity in an Associative CsCI Density 
Gradient Centrifugation * 
Medium  Cell layer 
Sp  Sp 
gravity  [3%]-DPM  gravity  [35S]-DPM 
g/ml  x  104  g/ml  x  104 
aA4  1.33  15.7 (26%)  1.32  6.8 (6%) 
aA3  1.40  8.2 (14%)  1.42  6.1 (6%) 
aA2  1.47  5.9 (10%)  1.50  17.3 (17%) 
aA1  1.60  30.1 (50%)  1.68  74.6 (71%) 
* These samples  were prepared from ~2 x  106 cells incubated with 50~tCi/ml 
of Na213%lO4 for 48 h. A portion of the labeled medium  (~35 ml of 10 ml) 
was taken for density gradients while the entire associative extract of the 
cell layer (~5 ml) was used for the density gradient. Of the material present 
in the medium,  ~78%  was recovered from the gradient  Likewise, ~53% of 
the  [35S] macromolecular  material  associated  with  the cell  layer was  re- 
covered from the gradient. 
associative conditions, dialyzed to  removed  CsC1  and  chro- 
matographed on an analytical Sepharose CL-2B column in an 
associative  solvent  as  described  in  Materials  and  Methods 
(Fig. 6a, b). Both samples contained a small percentage of the 
[35S]activity  (5-10%)  eluting  in  the  excluded  volume  where 
aggregate would be recovered. These results indicate that the 
majority of proteoglycans synthesized and  secreted into  the 
medium or extracted from the cell layer with associative sol- 
vents are not already bound in aggregate structures. 
An experiment was done to determine whether or not the 
proteoglycans synthesized by arterial smooth muscle cells pos- 
sess the capacity to form aggregate• An aliquot of each of the 
D 1 fractions from the medium and 4 M guanidine HC1 extracts 
of the  cell layer was mixed with excess carrier aA1  in 4  M 
guanidine HC1. After dialysis to 0.5 M sodium acetate, pH 7.0, 
to reassociate aggregates, each sample was eluted on Sepharose 
CL-2B in an associative solvent (Fig. 6 c, d). In each case, there 
was a pronounced shift in the [35S]sulfate-labeled large proteo- 
glycan  (K,v  =  0.31)  in  the  medium  and  cell  layer  to  the 
excluded volume of the column. A  similar shift was not ob- 
served  for  the  smaller proteoglycan populations.  Thus,  the 
proteoglycans in the aggregate fraction are derived from the 
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FIGURE  6  Sepharose CL-2 B profiles of proteoglycans present in the 
culture medium and cell layer eluted under associative conditions 
(0.5 M  sodium acetate, pH 7.0). Top panels (a and  b)  are  profiles 
obtained by chromatography of the bottom fraction of an associa- 
tive gradient (aA1) directly on an associative column without added 
carrier.  The bottom panels (cand  d) are profiles obtained when Dq 
fractions were mixed with excess aA1 carrier, allowed to reaggregate 
by dialysis against 0.5 M sodium acetate and eluted on an associative 
column.  The amount  of  radioactivity that  elutes  in  the Va of  the 
column serves as an estimate for the percentage aggregation. 
largest macromolecules, those which contained predominantly 
chondroitin sulfate. 
Electron Microscopy of the 
Isolated Proteoglycans 
Aliquots of the aAl fractions prepared without carrier from 
the  medium  and  cell  layer were  observed with  the electron 
microscope. Fig. 7 demonstrates a field with several individual 
monomers, some of which are circled. Individual molecules at 
a  higher  magnification  demonstrate  a  bottlebrush  structure 
consisting of a central filament containing side branches. Mea- 
surements of 300 individual, well-spread and isolated molecules 
indicate that the central filament of the bottlebrush structure 
varied between 57 and 242  nm with an average of 140 _  31 
nm. The number of side branches varied with filament length, 
but averaged eight for those monomers whose length was < 100 
nm.  Approximately 33% of the structures  were >100 nm in 
length  and  these  longer  monomers  frequently  contained  as 
many as  12-14 side branches. The average length of the side 
branches was -73 rim. Occasionally, structures with only one 
apparent side projection were observed (note dashed circles in 
Fig. 7) and may represent proteoglycans from the population 
of smaller macromolecules (peak II). No evidence of individual 
monomers aggregating into larger structures was observed. 
Electron Microscopy of the Intercellular Matrix 
of the Cultured Arterial Smooth Muscle Cells 
Safranin  O  staining  of the  cultures  (Fig.  8)  preserved  a 
matrix which was filled with short "brushlike" structures which 
in some sections resembled the structures identified in spreads 
of isolated proteoglycans shown in Fig. 7. There was evidence 
of filamentous projections emanating from a central core and 
when  these  structures  existed  free,  their  average length  was 
close  to  the  length  of purified  monomers  (140  nm).  These 
bottlebrush structures were entangled within and among Free 
fibrils as well as present singularly throughout the intercellular 
matrix (Fig. 8). In addition, in some sections they were observed 
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to  be  associated  with  the  plasma  membrane  of the  smooth 
muscle cells (Fig. 8, inset).  Chondroitinase ABC digestion was 
effective in removing these Safranin O preserved bottlebrush- 
like structures (data not shown). 
DISCUSSION 
Arterial  smooth  muscle  cells  derived  from  the  nonhuman 
primate, Macaca nemestrina, have been shown to synthesize at 
least two size classes of proteoglycans when cultured in vitro. 
The largest size class of proteoglycans was recovered primarily 
in the higher density fractions of CsC1 density gradients as has 
been reported for proteoglycans synthesized by other cell types 
in vitro (31,  38,  40,  43-47).  This large proteoglycan fraction 
gave similar elution profiles on molecular sizing columns for 
both the medium and cell layer (K,v =  0.31) and was shown to 
contain predominantly chondroitin sulfate chains with an av- 
erage weight of -40,000.  A  similar large chondroitin sulfate- 
containing proteoglycan population has been observed in cul- 
tures of glial cells (48), skin (49), and lung (50) fibroblasts and 
indicates that this class of proteoglycan may be synthesized by 
a  large number of noncartilagenous ceils.  This  proteoglycan 
resembles the major proteoglycan present in cartilage as well 
as those synthesized by differentiated chondrocytes in vitro in 
terms of its elution position on Sepharose CL-2B, but differs in 
possessing  chondroitin  sulfate  chains  of  higher  molecular 
weight (-40,000 vs.  -20,000) (45-47). Gardell et al.  (8)  have 
also  emphasized  the  similarity  of the  proteoglycan  derived 
from  aorta  and  cartilage  by  demonstrating  that  the  major 
proteoglycan isolated from bovine aorta reacted with antisera 
raised against that from cartilage.  In addition,  Mangkornka- 
nok-Mark et al. (51) demonstrated immunofluorescent staining 
of bovine aorta with antisera raised against cartilage proteogly- 
can. Furthermore, these investigators demonstrated that anti- 
sera raised against aortic proteoglycans only stained the peri- 
cellular  matrix  of cartilage while  anti-cartilage  proteoglycan 
stained both the pericellular and interterritorial zones of carti- 
lage.  These  results  demonstrate  that  proteoglycans  isolated 
from these two tissues may possess some immunologic similar- 
ities  as  well  as  some  differences.  The  large  proteoglycans 
produced by arterial smooth muscle cells appear to be able to 
interact with hyaluronic acid to form large molecular aggre- 
gates as has been demonstrated for cartilage  (38,  39).  These 
fmdings support the concept that the ability of proteoglycans 
to  aggregate  is  not  solely  restricted  to  cartilage.  The  large 
proteoglycan synthesized by arterial  smooth muscle cells  re- 
sembles  the  large  proteoglycan population  recently  isolated 
from human aorta by Salisbury and Wagner (6) in terms of: 
(a) elution position on Sepharose sizing columns; (b) glycos- 
aminoglycan composition; and (c) ability to form aggregate. 
The smaller proteoglycan present  in the medium contains 
dermatan  sulfate.  To some extent,  this  population resembles 
the small "ubiquitous" component produced by other mesen- 
chymal ceils in vitro (49, 50, 52, 53) and that recently isolated 
and  characterized  from  cartilage  (54).  Several  investigators 
have noticed the presence of dermatan sulfate proteoglycans in 
various  tissue  (55-59)  including  aorta  (1,  3,  4,  5,  55).  Most 
recently, Salisbury and Wagner (6) identified a dermatan sul- 
fate-containing proteoglycan of identical size to the dermatan 
sulfate proteoglycan synthesized and secreted into the medium 
by cultured primate arterial smooth muscle cells  described in 
this study. These results suggest that the arterial smooth muscle 
cells  retain  some  of their  differentiated  characteristics  with 
respect to proteoglycan biosynthesis. Similar conclusions were FIGURE  7  Electron micrographs of purified proteoglycans from  an associative density gradient (aA1)  of culture medium derived 
from  arterial  smooth  muscle  cells.  Circles  surround  individual  monomers  of  proteoglycans.  Dotted  circles  identify  monomers 
containing  only  one  side  projection.  Bar, 0.25  /xm.  x  64,000. Higher  magnification  of  individual  monomers  illustrates  their 
bottlebrush structure and polydispersity, b and  d are typical of monomers whose lengths are >100 nm, while  a and  c are typical 
of monomers whose length is <100 nm, Bar, 0.25 #m.  a, ×  140,000; b, x  147,000; c, x  165,000; and  d, x  156,300. 
reached regarding collagen biosynthesis by cultured nonhuman 
primate arterial smooth muscle cells (60). This is in contrast to 
some other cell  types which lose their capacity to synthesize 
tissue-specific proteoglycans when placed in culture (52). 
Although the majority of the glycosaminoglycans in the two 
proteoglycan peaks  produced  by arterial  smooth muscle cell 
cultures could be identified  as containing chondroitin sulfate 
or dermatan sulfate, a portion of each sulfate-containing peak 
resisted  degradation  with  enzymes specific for these  glycos- 
aminoglycans.  One  possibility  is  that  this  resistant  material 
represents  a  heparan  sulfate proteoglycan and recent experi- 
ments have demonstrated the presence of a  small amount of 
heparan  sulfate  proteoglycan in these  cultures  (Chang  et  al. 
Manuscript in preparation.).  In addition, heparan sulfate may 
have been present in the [asS]-labeled  population that eluted at 
the Vo from the cell  layer extracts  since Vogel and  Peterson 
(50) found heparan sulfate proteoglycans from lung fibroblast 
cultures to elute at this same position. Recently, Salisbury and 
Wagner (6) found a polydisperse heparan sulfate proteoglycan 
distributed  between the large and small proteoglycans in hu- 
man aorta. Oegema et al. (5) described the presence of a small 
proteoglycan  in  bovine  aorta  which  resisted  digestion  with 
chondroitinase  ABC  and  was  suggested  to  contain  heparan 
sulfate. It is unlikely that the smooth muscle cells are a major 
source of heparan sulfate in the blood vessel since endothelial 
cells  synthesize predominantly heparan sulfate proteoglycans 
(27, 61). 
The  marked  difference  in  the  relative  amount  of native 
WIGHT AND  HASCAL[  Proteoglycan  Synthesis by Arterial Smooth Muscle Cells  173 FIGURE  8  Electron  micrograph  of  a  portion  of  intercellular  matrix  of  an  arterial  smooth  muscle  cell  culture  prepared  in  the 
presence of Safranin O. Numerous short bottlebrush structures that exhibit an affinity for Safranin O can be recognized throughout 
the  intercellular  matrix  (arrows)  as  well  as  associated  with  fine  intercellular  fibrils.  Inset. Higher  magnification  of  a  similar 
preparation as  shown  in  Fig. 8,  demonstrating  that  some of  these "bottlebrush" structures  are associated with  the surface of 
arterial smooth muscle cells (smc). Bar, 0.2/~m.  x  78,000. 
proteoglycan aggregate produced by these cells versus the high 
capacity of the newly synthesized large proteoglycans to form 
aggregate when reconstituted with carrier cartilage proteogly- 
can is not understood. Native proteoglycan aggregate has been 
demonstrated in blood vessels (7, 8). It may be that the culture 
conditions are incorrect for aggregation to occur. For example, 
nonhuman primate arterial smooth muscle cells  produce very 
little  hyaluronic acid (21)  and availability of hyaluronic acid 
within these cultures may be limiting for aggregation to occur. 
In  addition,  no  information  is  yet  available  regarding  the 
ability of  these cells to produce link proteins which are essential 
for  the  formation  of stable  aggregates  (33).  However,  the 
f'mding that arterial smooth muscle cells synthesize and secrete 
two  distinct  proteoglycans which  differ  in  their  capacity  to 
form high molecular weight aggregates emphasizes the possible 
complexities  with  which  these  molecules  associate  with  one 
another as well as with other components in the arterial wall. 
Electron  microscopy  of the  aAl  fraction  from  both  the 
medium  and  cell  layer  of the  arterial  smooth  muscle  cell 
cultures  revealed a  heterogeneous population of macromole- 
cules which possessed  an  overall structure  of a  central  core 
with  various  numbers  of side  projections  along  its  length, 
similar to spread proteoglycan monomers isolated from carti- 
lage (39-41, 62). However, the average central core length was 
only one-third to one-half as long as the monomers isolated 
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from cartilage, while the side projections were approximately 
twice  as long. The side  projections  are  thought to represent 
glycosaminoglycans and the longer extended length of the side 
projections of the proteoglycans produced by arterial smooth 
muscle ceils  is consistent with their  higher molecular weight 
compared to cartilage proteoglycan (39--41, 61). 
Proteoglycans  could  also  .be  identified  morphologically 
within  the intercellular  matrix of the arterial  smooth muscle 
cell  cultures  using  Safranin  O  (42).  The  fine,  filamentous 
structures present throughout the matrix resembled the spread 
proteoglycan monomers and thus may represent the monomers 
in their  more extended  state  within  the  intercellular  matrix. 
Similar extended proteoglycan filaments have been observed 
by Scott (63) in tendon using a cinchomeronic dye. The pres- 
ervation of bottlebrush structures with Safranin O, which are 
susceptible to chondroitinase ABC digestion, is in contrast to 
the  granule-like  network  preserved  with  ruthenium  red  in 
cultures of arterial smooth muscle cells (25) and intact arteries 
(64,  65).  Granules  identified  in  ruthenium  red  preparations 
have  been  interpreted  to  represent  proteoglycan  monomers 
that have collapsed during processing (41). Safranin O appears 
to prevent collapse of the monomers. 
In  conclusion,  this  study  has  demonstrated  that  cultured 
arterial smooth muscle cells produce distinct species of proteo- 
glycans which resemble those present  in aortic tissue  in vivo and confirms the ability of this cell type to retain its differen- 
tiated function with respect to proteoglycan synthesis in vitro. 
The  finding  that  distinct  size classes  are  produced  by  these 
cells, which differ in their glycosaminoglycan composition and 
ability to aggregate, emphasizes the need to determine whether 
or not each of these populations differs in its location as well 
as its functional properties within blood vessels. Furthermore, 
it  will be  important  to  determine  whether  or not conditions 
that influence the synthesis of proteoglycans by arterial smooth 
muscle cells differentially affect  the production  of a  specific 
species of proteoglycans. Preliminary studies in our laboratory 
(66) suggest that rapidly dividing arterial smooth muscle cells 
synthesize proportionately more of the large chondroitin sulfate 
proteoglycan  than nondividing cells. Identifying such a  mod- 
ulation in proteoglycan  synthesis becomes  feasible using this 
culture  system  and  may  help  explain  changing  patterns  of 
arterial proteoglycans that occur during development and dis- 
ease in this tissue. 
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